BioStem Technologies Balance Sheet Health
Financial Health criteria checks 6/6
BioStem Technologies has a total shareholder equity of $22.8M and total debt of $4.2M, which brings its debt-to-equity ratio to 18.3%. Its total assets and total liabilities are $104.2M and $81.4M respectively. BioStem Technologies's EBIT is $23.2M making its interest coverage ratio 30.6. It has cash and short-term investments of $14.6M.
Key information
18.3%
Debt to equity ratio
US$4.17m
Debt
| Interest coverage ratio | 30.6x |
| Cash | US$14.61m |
| Equity | US$22.83m |
| Total liabilities | US$81.37m |
| Total assets | US$104.20m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: BSEM's short term assets ($101.4M) exceed its short term liabilities ($81.0M).
Long Term Liabilities: BSEM's short term assets ($101.4M) exceed its long term liabilities ($358.3K).
Debt to Equity History and Analysis
Debt Level: BSEM has more cash than its total debt.
Reducing Debt: BSEM had negative shareholder equity 5 years ago, but is now positive and has therefore improved.
Debt Coverage: BSEM's debt is well covered by operating cash flow (121%).
Interest Coverage: BSEM's interest payments on its debt are well covered by EBIT (30.6x coverage).